Effectivity and Safety of Irreversible Electroporation for Refractory Neoplasms in Liver and Pancreas

NCT02822066 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Refractory Neoplasms

Interventions

PROCEDURE: Electroporation

Sponsor

First Affiliated Hospital of Zhejiang University